Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances

March 3, 2011
Lycera Corp. and Merck have entered into an exclusive research collaboration to discover, develop and commercialize drug candidates to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis.   Read More »

March 3, 2011
Ricerca Biosciences has entered a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, to provide value-added capabilities to biopharma companies by creating a streamlined and efficient process to move a drug candidate from development t  Read More »

March 3, 2011
Lyophilization Services of New England, Inc. (LSNE) has recently completed a comprehensive FDA audit of its medical device manufacturing facility in Manchester, NH.   Read More »

March 3, 2011
Amyris, Inc. has entered into a contract manufacturing agreement with Antibióticos, S.A. to produce farnesene at Antibióticos’ facilities in León, Spain.   Read More »

March 3, 2011
Early and Late Stage revenues decline  Read More »

March 2, 2011
Jim McDermott has been appointed managing director of Quintiles’ Market Intelligence Practice for the Consulting group.  Read More »

March 2, 2011
IRX Therapeutics has signed a research collaboration agreement with a leading research-based pharmaceutical company to assess the potential effects of IRX-2 on the tumor microenvironment.  Read More »

March 2, 2011
PTC Therapeutics, through its Wellcome Trust collaboration, has identified a chemical series of molecules that penetrates the blood-brain barrier in animal models and reduces levels of BMI1, a protein linked to drug-resistant cancers.  Read More »

March 2, 2011
Celerion has completed a clean room and pharmacist certification to comply with USP 797 guidelines.  Read More »

March 1, 2011
Clondalkin Group has acquired the Printed Components business of Catalent Pharma Solutions.   Read More »

March 1, 2011
Advion BioServices plans to open a 22,000-sq.-ft. drug discovery bioanalytical lab in the Purdue Research Park in Indianapolis.   Read More »

March 1, 2011
Daiichi Sankyo Co. has entered an agreement to acquire Plexxikon, Inc. for $805 million up-front, with milestone payments associated with the approval of PLX4032 totaling an additional $130 million.  Read More »

March 1, 2011
Frontage Laboratories, Inc. has achieved AAALAC International accreditation.   Read More »

March 1, 2011
Amatsi (formerly known as CRID Pharma) and Avogadro will join forces in an effort to provide a broader range of drug development services to their respective pharma and biopharma clients.  Read More »

March 1, 2011
Excella GmbH in Feucht, Germany has met the criteria established under the SafeBridge program for Potent Compound Safety Certification and has been deemed competent and proficient in the safe handling of potent APIs and potent drug products for the manufa  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On